B. Metzler Seel. Sohn & Co. Holding Ag Bio Techne Corp Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Bio Techne Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 3,997 shares of TECH stock, worth $291,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,997
Previous 19,510
79.51%
Holding current value
$291,900
Previous $9.45 Million
3279.31%
% of portfolio
0.0%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
602Shares Held
151MCall Options Held
195KPut Options Held
53.2K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.34 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$688 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$467 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.66MShares$340 Million0.03% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.86B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...